Table 5:
The number of women who had each cotest result prior to one, two and three negative cotests, and the number and percentage of women diagnosed with CIN2+ by the prior cotest result
| N | CIN2+ (N) | CIN2+ (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HPV result at test preceding one negative cotest | ||||||||||||
| Cytology result at test preceding one negative cotest | HPV negative |
. | HPV positive |
Total | HPV negative |
. | HPV positive |
Total | HPV negative |
. | HPV positive |
Total |
| NILM | 58166 | 22035 | 799 | 81000 | 33 | 19 | 5 | 57 | 0.057 | 0.086 | 0.626 | 0.070 |
| . | 1431 | - | 5 | 1436 | 2 | - | 0 | 2 | 0.140 | 0.000 | 0.139 | |
| ASCUS | 274 | 106 | 372 | 752 | 0 | 0 | 2 | 2 | 0.000 | 0.000 | 0.538 | 0.266 |
| LSIL | 74 | 8 | 125 | 207 | 1 | 0 | 0 | 1 | 1.351 | 0.000 | 0.000 | 0.483 |
| High grade | 159 | 9 | 49 | 217 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | 0.000 |
| Total | 60104 | 22158 | 1350 | 83612 | 36 | 19 | 7 | 62 | 0.060 | 0.086 | 0.519 | 0.074 |
| ASCUS+ | 507 | 123 | 546 | 1176 | 1 | 0 | 2 | 3 | 0.197 | 0.000 | 0.366 | 0.255 |
| HPV result at test preceding two negative cotests | ||||||||||||
| Cytology result at test preceding two negative cotests | HPV negative |
. | HPV positive |
Total | HPV negative |
. | HPV positive |
Total | HPV negative |
. | HPV positive |
Total |
| NILM | 18858 | 9210 | 486 | 28554 | 9 | 2 | 1 | 12 | 0.048 | 0.022 | 0.206 | 0.042 |
| . | 597 | - | 12 | 609 | 1 | 0 | 1 | 0.168 | 0.000 | 0.164 | ||
| ASCUS | 925 | 121 | 75 | 1121 | 1 | 0 | 0 | 1 | 0.108 | 0.000 | 0.000 | 0.089 |
| LSIL | 35 | 11 | 16 | 62 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | 0.000 |
| High-grade | 37 | 3 | 7 | 47 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | 0.000 |
| Total | 20452 | 9345 | 596 | 30393 | 11 | 2 | 1 | 14 | 0.054 | 0.021 | 0.168 | 0.046 |
| ASCUS+ | 997 | 135 | 98 | 1230 | 1 | 0 | 0 | 1 | 0.100 | 0.000 | 0.000 | 0.081 |
| HPV result at test preceding three negative cotests | ||||||||||||
| Cytology result at test preceding three negative cotests | HPV negative |
. | HPV positive |
Total | HPV negative |
. | HPV positive |
Total | HPV negative |
. | HPV positive |
Total |
| NILM | 2434 | 2011 | 69 | 4514 | 1 | 0 | 0 | 1 | 0.041 | 0.000 | 0.000 | 0.022 |
| . | 58 | 2 | 60 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | |||
| ASCUS | 89 | 27 | 2 | 118 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | 0.000 |
| LSIL | 3 | 1 | 1 | 5 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | 0.000 |
| High-grade | 6 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | ||
| Total | 2590 | 2039 | 74 | 4703 | 1 | 0 | 0 | 1 | 0.039 | 0.000 | 0.000 | 0.021 |
| ASCUS+ | 98 | 28 | 3 | 129 | 0 | 0 | 0 | 0 | 0.000 | 0.000 | 0.000 | 0.000 |
NILM: negative for intraepithelial lesions or malignancy, ASCUS: atypical squamous cells of undetermined significance, LSIL: low grade squamous intraepithelial lesion